OTCMKTS:ABCZY Abcam (ABCZY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Abcam Stock (OTCMKTS:ABCZY) Get Abcam alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5,400 shsAverage Volume4,712 shsMarket Capitalization$3.98 billionP/E RatioN/ADividend Yield0.36%Price TargetN/AConsensus RatingN/A Company Overview Abcam plc was a life sciences company that developed, manufactured and distributed biological research products for academic, pharmaceutical, biotechnology and clinical research organizations. Its portfolio included primary and secondary antibodies, recombinant proteins, immunoassays, proteins, peptides and assay kits used in applications such as cell biology, immunology, neuroscience, cancer research and drug development. Founded in 1998 by Jonathan Milner, Abcam was headquartered in Cambridge, United Kingdom, and served customers through operations and distribution networks across North America, Europe, Asia and other international markets. The company provided products through online ordering, technical support and research-focused digital resources. In 2023, Abcam was acquired by Danaher Corporation and ceased operating as an independent publicly traded company. Its products and capabilities became part of Danaher's life sciences business portfolio.AI Generated. May Contain Errors. Read More Receive ABCZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABCZY Stock News HeadlinesAbcam PLC PK Stock Price HistoryJune 12, 2026 | investing.comAbcam launches SimpleStep Ignite™ ELISA: an innovative assay platform that combines 50x higher sensitivity and up to 35x wider dynamic range in only 55 minutesApril 13, 2026 | finance.yahoo.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. | Banyan Hill Publishing (Ad)Molecular Instruments and Abcam Announce Broad Compatibility of the HCR™ HiFi Encoder with Abcam’s Best-in-Class RabMAb® and Mouse Antibody PortfolioOctober 21, 2025 | finance.yahoo.comDanaher deal for Abcam approved by 89 per cent of shareholdersNovember 7, 2023 | msn.comAbcam shareholders approve $5.7 billion Danaher dealNovember 6, 2023 | uk.news.yahoo.comAbcam founder ends fight to block takeoverNovember 1, 2023 | thetimes.co.ukTLeading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of AbcamOctober 23, 2023 | finance.yahoo.comSee More Headlines ABCZY Stock Analysis - Frequently Asked Questions Does Abcam have any subsidiaries? Abcam subsidiaries include these companies: Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., Abcam (US) Ltd., and Epitomics Inc. How do I buy shares of Abcam? Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CIKN/A Webwww.abcam.com Phone44 1223 696 000FaxN/AEmployees1,750Year Founded1998Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$336.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares205,080,000Free FloatN/AMarket Cap$3.98 billion OptionableNot Optionable Beta1.29 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:ABCZY) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredLook at Elon’s face after meeting with ChinaElon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Ex...International Living | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abcam With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
